WallStreetZenWallStreetZen

NASDAQ: VACC
Vaccitech PLC Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for VACC

Based on 3 analysts offering 12 month price targets for Vaccitech PLC.
Min Forecast
$16.00+421.17%
Avg Forecast
$19.33+529.74%
Max Forecast
$22.00+616.61%

Should I buy or sell VACC stock?

Based on 3 analysts offering ratings for Vaccitech PLC.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VACC stock forecasts and price targets.

VACC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 2%
2
Strong BuyMaintains$16.00+421.17%2022-08-15
HC Wainwright & Co.
Top 5%
96
BuyMaintains$20.00+551.47%2022-08-11
Anonymous
Morgan Stanley
Strong BuyMaintains$19.00+518.89%2022-05-17
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$22.00+616.61%2022-05-13

1 of 1

Forecast return on equity

Is VACC forecast to generate an efficient return?
Company
-31.7%
Industry
18.78%
Market
118.57%
VACC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VACC forecast to generate an efficient return on assets?
Company
-28.33%
Industry
14.1%
VACC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VACC earnings per share forecast

What is VACC's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.55
Avg 2 year Forecast
-$2.23
Avg 3 year Forecast
-$2.67

VACC revenue forecast

What is VACC's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$34.4M+7.25%
Avg 2 year Forecast
$9.3M-71.18%
Avg 3 year Forecast
$6.9M-78.61%
VACC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VACC revenue growth forecast

How is VACC forecast to perform vs Biotechnology companies and vs the US market?
Company
-59.91%
Industry
23.75%
Market
8.46%
VACC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VACC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VACC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VACC$3.07$19.33+529.74%Strong Buy
STTK$2.70$18.50+585.19%Strong Buy
PRAX$2.50$10.67+326.68%Buy
ENOB$2.15N/AN/A
GLSI$8.84$78.00+782.35%Strong Buy

Vaccitech Stock Forecast FAQ

Is Vaccitech Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: VACC) stock is to Strong Buy VACC stock.

Out of 3 analysts, 1 (33.33%) are recommending VACC as a Strong Buy, 2 (66.67%) are recommending VACC as a Buy, 0 (0%) are recommending VACC as a Hold, 0 (0%) are recommending VACC as a Sell, and 0 (0%) are recommending VACC as a Strong Sell.

If you're new to stock investing, here's how to buy Vaccitech stock.

What is VACC's earnings growth forecast for 2022-2024?

(NASDAQ: VACC) Vaccitech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.67%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Vaccitech's earnings in 2022 is -$1,381,000.On average, 3 Wall Street analysts forecast VACC's earnings for 2022 to be -$20,468,889, with the lowest VACC earnings forecast at -$43,915,071, and the highest VACC earnings forecast at -$4,093,778. On average, 4 Wall Street analysts forecast VACC's earnings for 2023 to be -$82,992,041, with the lowest VACC earnings forecast at -$93,784,728, and the highest VACC earnings forecast at -$68,849,900.

In 2024, VACC is forecast to generate -$99,367,153 in earnings, with the lowest earnings forecast at -$107,554,708 and the highest earnings forecast at -$86,713,657.

What is VACC's revenue growth forecast for 2022-2024?

(NASDAQ: VACC) Vaccitech's forecast annual revenue growth rate of -59.91% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Vaccitech's revenue in 2022 is $32,099,000.On average, 4 Wall Street analysts forecast VACC's revenue for 2022 to be $1,281,166,377, with the lowest VACC revenue forecast at $659,470,391, and the highest VACC revenue forecast at $1,838,478,403. On average, 4 Wall Street analysts forecast VACC's revenue for 2023 to be $344,249,499, with the lowest VACC revenue forecast at $39,076,970, and the highest VACC revenue forecast at $1,004,836,374.

In 2024, VACC is forecast to generate $255,526,168 in revenue, with the lowest revenue forecast at $66,989,092 and the highest revenue forecast at $632,674,754.

What is VACC's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: VACC) forecast ROA is -28.33%, which is lower than the forecast US Biotechnology industry average of 14.1%.

What is VACC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VACC price target, the average VACC price target is $19.33, with the highest VACC stock price forecast at $22.00 and the lowest VACC stock price forecast at $16.00.

On average, Wall Street analysts predict that Vaccitech's share price could reach $19.33 by Aug 15, 2023. The average Vaccitech stock price prediction forecasts a potential upside of 529.74% from the current VACC share price of $3.07.

What is VACC's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: VACC) Vaccitech's current Earnings Per Share (EPS) is -$0.02. On average, analysts forecast that VACC's EPS will be -$0.55 for 2022, with the lowest EPS forecast at -$1.18, and the highest EPS forecast at -$0.11. On average, analysts forecast that VACC's EPS will be -$2.23 for 2023, with the lowest EPS forecast at -$2.52, and the highest EPS forecast at -$1.85. In 2024, VACC's EPS is forecast to hit -$2.67 (min: -$2.89, max: -$2.33).

What is VACC's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: VACC) forecast ROE is -31.7%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.